← Back to patent-cliff list
CAS 225112-16-3
(6-chloropyridin-2-yl)(1-methylpiperidin-4-yl)methanone
Codes：LASM-011
Application context (from source-drug indications)
偏头痛半琥珀酸拉米地坦药物相关的副作用和不良反应半琥珀酸拉米地坦
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 半琥珀酸拉米地坦Lasmiditan hemisuccinate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(6-aminopyridin-2-yl)(1-methylpiperidin-4-yl)methanone→2,4,6-trifluorobenzoyl chloride→2-chloropyridine→N-methoxy-N,1-dimethylpiperidine-4-carboxamide→(6-chloropyridin-2-yl)(1-methylpiperidin-4-yl)methanone→diphenylmethanimine→(6-((diphenylmethylene)amino)pyridin-2-yl)(1-methylpiperidin-4-yl)methanone
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.